Mirati Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
25 Jan 2024	Form 4: Boxer Capital, Llc, See remarks and 8 others Returned 6,859,544 shares to the issuer · Disposed of 5,324,320 Warrant (right to purchase) (Disposition to Issuer)
23 Jan 2024	Form 4: Sharp Shalini, Director Returned 16,222 shares to the issuer · Disposed of 7,520 Option to Purchase Common Stock (Disposition to Issuer)
23 Jan 2024	Form 4: Cherrington Julie M, Director Returned 11,252 shares to the issuer · Disposed of 7,520 Option to Purchase Common Stock (Disposition to Issuer)
23 Jan 2024	Form 4: Davis Aaron I., Director Returned 54,325 shares to the issuer · Disposed of 43,520 Option to Purchase Common Stock (Disposition to Issuer)
23 Jan 2024	Form 4: Carter Bruce L A, Director Returned 17,273 shares to the issuer · Disposed of 28,520 Option to Purchase Common Stock (Disposition to Issuer)
23 Jan 2024	Form 4: Johnson Craig A, Director Returned 17,273 shares to the issuer · Disposed of 56,520 Option to Purchase Common Stock (Disposition to Issuer)
23 Jan 2024	Form 4: Hasnain Faheem, Director Returned 24,752 shares to the issuer · Disposed of 55,716 Option to Purchase Common Stock (Disposition to Issuer)
23 Jan 2024	Form 4: Ondrey Aaron, Chief Financial Officer Returned 39,461 shares to the issuer · Disposed of 23,837 Option to Purchase Common Stock (Disposition to Issuer)
23 Jan 2024	Form 4: Moriarty John B, Chief Legal Officer Returned 72,335 shares to the issuer · Disposed of 83,525 Option to Purchase Common Stock (Disposition to Issuer)
23 Jan 2024	Form 4: Hickey Benjamin, EVP, Chief Commercial Officer Returned 117,028 shares to the issuer · Disposed of 45,456 Option to Purchase Common Stock (Disposition to Issuer)
23 Jan 2024	Form 4: Martinez Maria E, Director Returned 17,273 shares to the issuer · Disposed of 36,020 Option to Purchase Common Stock (Disposition to Issuer)
23 Jan 2024	Form 4: Sandler Alan B., Chief Medical Officer Returned 79,865 shares to the issuer · Disposed of 65,000 Option to Purchase Common Stock (Disposition to Issuer)
23 Jan 2024	Form 4: Christensen Jamie, EVP & Chief Scientific Officer Returned 154,996 shares to the issuer · Disposed of 313,414 Option to Purchase Common Stock (Disposition to Issuer)
23 Jan 2024	Form 4: Baum Charles M, Director Returned 237,871 shares to the issuer · Disposed of 718,213 Option to Purchase Common Stock (Disposition to Issuer)
23 Jan 2024	Form 4: Gallagher Carol Giltner, Director Returned 14,363 shares to the issuer · Disposed of 12,784 Option to Purchase Common Stock (Disposition to Issuer)
18 Jan 2024	Form 4: Hickey Benjamin, EVP, Chief Commercial Officer Sold 1,597 shares ($94.3K)
18 Jan 2024	Form 4: Christensen Jamie, EVP & Chief Scientific Officer Sold 1,597 shares ($94.3K)
09 Jan 2024	Form 4: Hickey Benjamin, EVP, Chief Commercial Officer Sold 2,090 shares ($123K)
05 Jan 2024	Form 4: Christensen Jamie, EVP & Chief Scientific Officer Sold 1,531 shares ($90K)
03 Jan 2024	Form 4: Davis Aaron I., Director Received 6,808 shares as a grant or award ($400K)

Comments